NOTE
6 – EARNINGS PER COMMON SHARE
Earnings
(loss) per common share-basic is calculated by dividing net income (loss) by the weighted average number of shares of common stock outstanding
during the period. Net income (loss) per common share-diluted assumes the conversion of all potentially dilutive securities and is calculated
by dividing net (loss) income by the sum of the weighted average number of shares of common stock, as defined above, outstanding plus
potentially dilutive securities. Net income per common share-diluted considers the impact of potentially dilutive securities. In periods
in which there is a loss because the inclusion of the potential common shares, as defined above, would have an anti-dilutive effect.
The
calculation of earnings (loss) per common share for the periods indicated below were as follows:
SCHEDULE
OF EARNINGS (LOSS) PER COMMON SHARE
| |
| | | |
| | |
| |
Three Months Ended March 31, | |
| |
2025 | | |
2024 | |
Numerator: | |
| | |
| |
Net loss | |
$ | (1,032,483 | ) | |
$ | (15,699 | ) |
| |
| | | |
| | |
Effect of common stock equivalents | |
| — | | |
| — | |
Net loss adjusted for common stock equivalents | |
$ | (1,032,483 | ) | |
$ | (15,699 | ) |
| |
| | | |
| | |
Denominator: | |
| | | |
| | |
Weighted average common shares – basic | |
| 15,050,977 | | |
| 10,906,353 | |
| |
| | | |
| | |
Dilutive effect of common stock equivalents: | |
| | | |
| | |
Options and warrants | |
| — | | |
| — | |
| |
| | | |
| | |
Denominator: | |
| | | |
| | |
Weighted average common shares – diluted | |
| 15,050,977 | | |
| 10,906,353 | |
| |
| | | |
| | |
Loss per common share – basic | |
$ | (0.07 | ) | |
$ | (0.00 | ) |
| |
| | | |
| | |
Loss per common share – diluted | |
$ | (0.07 | ) | |
$ | (0.00 | ) |
For
the three months ended March 31, 2025 and 2024, the following warrants and options to purchase shares of common stock were excluded from
the computation of diluted net income (loss) per common share, as the inclusion of such shares would be anti-dilutive:
SCHEDULE
OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF DILUTED NET INCOME LOSS
| |
| | | |
| | |
| |
Three Months Ended March 31, | |
| |
2025 | | |
2024 | |
Stock warrants | |
| 94,400 | | |
| 94,400 | |
Stock options | |
| 965,846 | | |
| 908,139 | |
Total | |
| 1,060,246 | | |
| 1,002,539 | |
|